Science News Today
  • Biology
  • Physics
  • Chemistry
  • Astronomy
  • Health and Medicine
  • Psychology
  • Earth Sciences
  • Archaeology
  • Technology
Science News Today
  • Biology
  • Physics
  • Chemistry
  • Astronomy
  • Health and Medicine
  • Psychology
  • Earth Sciences
  • Archaeology
  • Technology
No Result
View All Result
Science News Today
No Result
View All Result
Home Health and Medicine

Bile Acids Impair T Cell Function and Promote Tumor Growth in Liver Cancer

by Muhammad Tuhin
January 16, 2025
Bile Acids Impair T Cell Function and Promote Tumor Growth in Liver Cancer

A scientist carrying supplements—like UDCA—climbs a ladder toward a liver containing a bile acid-surrounded tumor. Credit: Salk Institute

0
SHARES
Share on FacebookShare on Twitter

Immunotherapy has revolutionized cancer treatment in recent years, offering patients the potential for more personalized and effective therapies. By harnessing the power of the immune system, immunotherapy helps the body’s natural defenses fight cancer more effectively. It has proven to be an impactful approach for several types of cancer, including those affecting the lung, kidney, and bladder. However, when it comes to liver cancer, the results have been less impressive, sparking concerns as liver cancer rates have nearly tripled globally in the past four decades.

You might also like

The Weight Loss Medication That Might Stop Migraines

Your Brain Holds the Secret to How Long You’ll Stay Healthy

How Cancer Steals Power from Nerves to Spread Through the Body

A growing body of research has sought to understand why immunotherapy tends to be less effective in liver cancer. Scientists have found intriguing answers by exploring the complex interactions between the liver’s environment and the immune system. One significant finding comes from the Salk Institute, where a team of researchers recently uncovered how bile acids in the liver could hinder the body’s immune response against liver tumors.

The Role of Bile Acids in Liver Cancer

Bile acids, which are produced by the liver, play a critical role in digestion and the metabolism of fats in the intestines. The liver produces over 100 different types of bile acids, some of which are conjugated—chemically modified—during their circulation. While bile acids are essential for maintaining digestive health, they may have a much more significant impact than previously recognized in the context of liver disease and cancer. Bile acids are known to contribute to certain disease states, including cancer, and have been shown to negatively affect immune system function, especially in the liver.

Recent studies at the Salk Institute have focused on identifying how bile acids directly influence the function of immune cells, known as T cells, which are key players in the body’s fight against cancer. The liver’s unique cellular environment may impact how T cells are activated and how well they perform their immune functions within the liver. Through these studies, researchers were able to identify specific bile acids that impair T cell activity, contributing to the growth and survival of liver tumors.

Dr. Susan Kaech, the senior author of the study and Director of Salk’s NOMIS Center for Immunobiology and Microbial Pathogenesis, explained that liver-specific features were previously underexplored. “How do organ-specific properties and processes influence the immune response?” Kaech asked, leading to the discovery of critical factors influencing T cell behavior in the liver’s distinct environment. The research suggests that certain bile acids directly inhibit T cell performance, promoting tumor growth in liver cancer patients.

Key Discoveries About Bile Acids and Tumor Growth

The Salk researchers’ investigation involved several stages. First, they cataloged the bile acids present in human liver cancer biopsies. The results revealed that the liver tumor samples contained elevated levels of conjugated bile acids compared to healthy tissues. This observation led the researchers to ask whether these conjugated bile acids were playing a direct role in cancer progression.

To test this hypothesis, the team focused on a specific enzyme, BAAT (bile acid-CoA:amino acid N-acyltransferase), which produces conjugated bile acids. When they removed BAAT from the experimental mice, the researchers observed a notable reduction in tumor burden, pointing to the idea that regulating the levels of conjugated bile acids—specifically by controlling BAAT production—could improve the efficacy of immunotherapies for liver cancer.

Impact on T Cell Function

After addressing the role of bile acid production in liver cancer progression, the researchers delved deeper into how different bile acids directly affected the function of immune cells. They isolated 20 different bile acids and examined their impact on T cells. Interestingly, the bile acids were shown to have different effects based on their chemical composition and the pathways they triggered in the immune system.

Some primary bile acids had minimal impact, while others, like TCDCA (taurocholic acid), induced oxidative stress in T cells. Oxidative stress damages the integrity of cells and tissues, preventing the T cells from performing their cancer-fighting functions. More impactful, however, were secondary bile acids, especially two: LCA (lithocholic acid) and UDCA (ursodeoxycholic acid).

LCA was found to cause endoplasmic reticulum (ER) stress within T cells. This stress hindered the ability of the T cells to fold and modify proteins correctly, impairing their immune response. On the other hand, UDCA, an otherwise common bile acid used to treat liver diseases such as primary biliary cholangitis, had a positive impact on T cell function. UDCA enhanced the recruitment of immune cells to liver tumors and promoted healthier T cell activity.

Through dietary supplementation of UDCA, the team was able to control tumor growth in mice suffering from liver cancer. Since UDCA is already used to treat other liver diseases, this could present an easy and promising way to improve the outcomes of immunotherapy for liver cancer patients.

Implications for Immunotherapy and Future Treatments

The findings from the Salk Institute hold significant potential for enhancing immunotherapy for liver cancer. Professor Kaech, also the NOMIS Chair at Salk, is excited about the clinical implications of this work, especially since UDCA supplementation is already in use for other liver diseases. Because of this, UDCA could easily be integrated into liver cancer treatment strategies, potentially making existing immunotherapies more effective.

“By investigating liver-specific bile acids, we are not only revealing new ways to boost the performance of T cells, but we are also identifying molecular targets that could help revolutionize liver cancer treatment,” Dr. Kaech stated.

These new insights challenge the standard approach to liver cancer treatment by considering the liver’s complex biological environment in a new light. For a long time, scientists have tried to improve cancer treatments by focusing only on the tumor itself, often overlooking the host’s surrounding environment and immune function. The Salk researchers have shown that organ-specific features like bile acid profiles in the liver matter considerably in influencing how immune cells function, opening up fresh perspectives in cancer immunotherapy.

Exploring the Gut Microbiome and Future Research

In addition to dietary changes such as UDCA supplementation, the Salk researchers also highlighted the potential role of the gut microbiome in regulating bile acid levels. Since bile acids are closely linked with gut bacteria, researchers are beginning to explore how manipulating the microbiome could influence cancer treatments. Certain bacteria are thought to modify bile acid metabolism, possibly affecting cancer progression and the immune response. For example, “good” bacteria in the gut might reduce harmful bile acid levels, thereby improving the immune response in liver cancer.

Additionally, the research team is considering the potential use of probiotics as a therapeutic strategy. Could introducing specific probiotic strains into a patient’s gut microbiome improve liver cancer treatment outcomes by regulating bile acid levels? Future studies into the microbiome’s influence on liver cancer may lead to new combination treatments, integrating probiotic-based therapies with existing immunotherapy approaches.

Broader Applications Beyond Liver Cancer

While much of this research focuses on liver cancer, the implications extend beyond just one organ system. The discovery that regulating bile acids can influence T cell function opens new opportunities for addressing other conditions and diseases, especially chronic liver conditions like cirrhosis or obesity. The findings suggest that targeting BAAT to reduce conjugated bile acid levels could benefit patients with chronic liver diseases, in addition to those with liver cancer.

As the team continues their exploration of the relationship between bile acids, the immune system, and liver cancer, they aim to test their findings in human clinical trials. The hope is that manipulating bile acid levels will significantly improve the efficacy of immunotherapy, offering a new line of treatment for liver cancer and beyond.

Conclusion

The work from the Salk Institute has revealed an exciting new frontier in liver cancer treatment, highlighting how liver-specific bile acids influence immune response. By targeting key bile acids like UDCA to boost T cell activity and suppress tumor growth, the researchers have opened a new window for enhancing immunotherapy. With further exploration into the gut microbiome and the broader clinical applications of bile acid regulation, there is a lot of optimism that these findings will transform the way liver cancer and other chronic liver conditions are treated in the future.

Reference: Siva Karthik Varanasi et al, Bile acid synthesis impedes tumor-specific T cell responses during liver cancer, Science (2025). DOI: 10.1126/science.adl4100

Love this? Share it and help us spark curiosity about science!

ShareTweetPin

Recommended For You

The Weight Loss Medication That Might Stop Migraines
Health and Medicine

The Weight Loss Medication That Might Stop Migraines

July 3, 2025
Your Brain Holds the Secret to How Long You’ll Stay Healthy
Health and Medicine

Your Brain Holds the Secret to How Long You’ll Stay Healthy

July 3, 2025
How Cancer Steals Power from Nerves to Spread Through the Body
Health and Medicine

How Cancer Steals Power from Nerves to Spread Through the Body

July 3, 2025
Your Brain Burns Fat When It’s Hungry for Thoughts
Health and Medicine

Your Brain Burns Fat When It’s Hungry for Thoughts

July 3, 2025
Plastic Found in Human Reproductive Fluids Sparks Alarming Questions
Health and Medicine

Plastic Found in Human Reproductive Fluids Sparks Alarming Questions

July 3, 2025
Scientists Grow Mini Human Hearts That Could Transform Medicine
Health and Medicine

Scientists Grow Mini Human Hearts That Could Transform Medicine

July 3, 2025
Why Non-Smokers Are Getting Lung Cancer at Alarming Rates
Health and Medicine

Why Non-Smokers Are Getting Lung Cancer at Alarming Rates

July 3, 2025
Scientists Discover a Natural Molecule That Fights Inflammation and Aging Like Exercise
Health and Medicine

Scientists Discover a Natural Molecule That Fights Inflammation and Aging Like Exercise

July 3, 2025
Scientists Discover a Hormone in Fat That Extends Lifespan in Obese Mice
Health and Medicine

Scientists Discover a Hormone in Fat That Extends Lifespan in Obese Mice

July 3, 2025
Next Post
300 Previously Unknown Genes Linked to Depression in Global Populations

300 Previously Unknown Genes Linked to Depression in Global Populations

“GroceryDB” Reveals the Extent of Food Processing in Major US Retailers

"GroceryDB" Reveals the Extent of Food Processing in Major US Retailers

Sexually Dimorphic Dopaminergic Circuits Determine Sex Preference and Are Reversed by Stress

Sexually Dimorphic Dopaminergic Circuits Determine Sex Preference and Are Reversed by Stress

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Legal

  • About Us
  • Contact Us
  • Disclaimer
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

© 2025 Science News Today. All rights reserved.

No Result
View All Result
  • Biology
  • Physics
  • Chemistry
  • Astronomy
  • Health and Medicine
  • Psychology
  • Earth Sciences
  • Archaeology
  • Technology

© 2025 Science News Today. All rights reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok